{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:57:20Z","timestamp":1790459840729,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Minister of Education, Culture, Sports, Science, and Technology"},{"name":"Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology"},{"name":"Stony Brook Foundation"},{"name":"Reata Pharmaceuticals"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejphar.2016.10.037","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:47:24Z","timestamp":1478047644000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression"],"prefix":"10.1016","volume":"793","author":[{"given":"Wei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.10.037_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-011-2619-3","article-title":"Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine","volume":"222","author":"Chen","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.10.037_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2016.10.037_bib3","doi-asserted-by":"crossref","first-page":"33747","DOI":"10.1074\/jbc.M110.163485","article-title":"An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1","volume":"285","author":"Dinkova-Kostova","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.10.037_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2016.02.005","article-title":"Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration","volume":"144","author":"Dong","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.10.037_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2016.10.037_bib6","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammatory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2016.10.037_bib7","doi-asserted-by":"crossref","first-page":"e15430","DOI":"10.1371\/journal.pone.0015430","article-title":"A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation factor eIF4AI","volume":"5","author":"Hashimoto","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2016.10.037_bib8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/jm070141c","article-title":"Novel tricyclic compounds having acetylene groups at C-8a and cyano enones in rings A and C: highly potent anti-inflammatory and cytoprotective agents","volume":"50","author":"Honda","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.10.037_bib9","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/jm101445p","article-title":"Tricyclic compounds containing nonenolizable cyano enones: a novel class of highly potent anti-inflammatory and cytoprotective agents","volume":"54","author":"Honda","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.10.037_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Innamorato","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2016.10.037_bib11","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1038\/tp.2012.97","article-title":"Neurite outgrowth mediated by the heat shock protein Hsp90\u03b1: a novel target for the antipsychotic drug aripiprazole","volume":"2","author":"Ishima","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.10.037_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.euroneuro.2015.01.014","article-title":"Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors","volume":"25","author":"Ishima","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.10.037_bib13","doi-asserted-by":"crossref","first-page":"529219","DOI":"10.1155\/2013\/529219","article-title":"Roles nrf2 plays in myeloid cells and related disorders","volume":"2013","author":"Kobayashi","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2016.10.037_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbrc.2015.08.016","article-title":"Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action","volume":"465","author":"Kostov","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2016.10.037_bib15","first-page":"139","article-title":"An important role of Nrf2-ARE pathway in the cellular defense mechanism","volume":"37","author":"Lee","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2016.10.037_bib16","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1158\/0008-5472.CAN-08-1123","article-title":"A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin","volume":"68","author":"Liby","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2016.10.037_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/JMN:27:1:043","article-title":"Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K\/AKT, ERK, and pertussis toxin-sensitive pathways","volume":"27","author":"Lu","year":"2005","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2016.10.037_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.9758\/cpn.2014.12.1.31","article-title":"Effects of brilliant blue G on serum tumor necrosis factor-\u03b1 levels and depression-like behavior in mice after lipopolysaccharide administration","volume":"12","author":"Ma","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ejphar.2016.10.037_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2016.10.037_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/pr.110.004333","article-title":"Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2","volume":"64","author":"Ma","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2016.10.037_bib21","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.psyneuen.2013.03.020","article-title":"Nrf2 participates in depressive disorders through an anti-inflammatory mechanism","volume":"38","author":"Mart\u00edn-de-Saavedra","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2016.10.037_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.04.036","article-title":"Nrf2-signaling and BDNF: a new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety\/depression","volume":"597","author":"Mendez-David","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2016.10.037_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.10.037_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/BST20150069","article-title":"The Keap1\/Nrf2 pathway in health and disease: from the bench to the clinic","volume":"43","author":"O'Connell","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2016.10.037_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenaseactivation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.10.037_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.pbb.2012.12.003","article-title":"Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration","volume":"103","author":"Ohgi","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.10.037_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2010.07.015","article-title":"Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice","volume":"215","author":"de Paiva","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.10.037_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archgenpsychiatry.2010.161","article-title":"Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression","volume":"67","author":"Raison","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.10.037_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.9758\/cpn.2012.10.2.94","article-title":"Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration","volume":"10","author":"Shirai","year":"2012","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ejphar.2016.10.037_bib30","doi-asserted-by":"crossref","first-page":"e0127244","DOI":"10.1371\/journal.pone.0127244","article-title":"Dietary intake of sulforaphane-rich broccoli sprout extracts during Juvenile and adolescence can prevent phencyclidine-induced cognitive deficits at adulthood","volume":"10","author":"Shirai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2016.10.037_bib31","doi-asserted-by":"crossref","first-page":"e1001403","DOI":"10.1371\/journal.pmed.1001403","article-title":"Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes","volume":"10","author":"Spielmans","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejphar.2016.10.037_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2016.10.037_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","article-title":"Toward clinical application of the Keap1-Nrf2 pathway","volume":"34","author":"Suzuki","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2016.10.037_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2016.10.037_bib35","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1471-4159.2009.06291.x","article-title":"Structure-based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor","volume":"110","author":"Williams","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2016.10.037_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1517\/13543784.2015.1055669","article-title":"Peripheral IL-6 signaling: a promising therapeutic target for depression?","volume":"24","author":"Yang","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2016.10.037_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1017\/neu.2015.36","article-title":"Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress","volume":"27","author":"Yang","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2016.10.037_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2015.06.012","article-title":"Effects of amycenone on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration","volume":"136","author":"Yao","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.10.037_bib39","doi-asserted-by":"crossref","first-page":"30659","DOI":"10.1038\/srep30659","article-title":"Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanine confers stress resilience in mice","volume":"6","author":"Yao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2016.10.037_bib40","doi-asserted-by":"crossref","unstructured":"Zhang, J.C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Wu, J., Ushida, Y., Suganuma, H., Hashimoto, K. Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation. J. Nutri. Biochem. (in press), http:\/\/dx.doi.org\/10.1016\/j.jnutbio.2016.10.004.","DOI":"10.1016\/j.jnutbio.2016.10.004"},{"key":"10.1016\/j.ejphar.2016.10.037_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu077","article-title":"Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation","volume":"18","author":"Zhang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.10.037_bib42","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.10.037_bib43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/1570159X14666160119094646","article-title":"Brain-derived neurotrophic factor (BDNF) \u2013 TrkB signaling in inflammation-related depression and potential therapeutic targets","volume":"14","author":"Zhang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2016.10.037_bib44","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1021\/jm3003922","article-title":"Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents","volume":"55","author":"Zheng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.10.037_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv060","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991630677X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991630677X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T01:22:55Z","timestamp":1655947375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991630677X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":45,"alternative-id":["S001429991630677X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.10.037","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}